Intellia Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Intellia Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 30% to $36,275,000. The net income raised on -$481,192,000 and profit margin reached -1327%. Total operating expenses were $551,566,000.
Profit Margin
| 2014 | 0 | -14.30M | |
|---|---|---|---|
| 2015 | 6.04M | -12.39M | -205.11% |
| 2016 | 16.47M | -31.63M | -191.97% |
| 2017 | 26.11M | -67.54M | -258.62% |
| 2018 | 30.43M | -85.34M | -280.42% |
| 2019 | 43.10M | -92.69M | -215.06% |
| 2020 | 57.99M | -125.56M | -216.52% |
| 2021 | 33.05M | -259.71M | -785.76% |
| 2022 | 52.12M | -490.20M | -940.52% |
| 2023 | 36.27M | -481.19M | -1326.51% |
NTLA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 36.27M | 52.12M | 33.05M | 57.99M | 43.10M | 30.43M | 26.11M | 16.47M | 6.04M | 0 |
Cost of revenue | 8.97M | 7.57M | 6.89M | 150.40M | 108.41M | 0 | 67.64M | 0 | 11.17M | 1.65M |
Gross profit | 27.29M | 44.54M | 26.16M | -92.41M | -65.31M | 30.43M | -41.53M | 16.47M | -5.12M | -1.65M |
Operating exp. | ||||||||||
Research and development | 435.06M | 419.97M | 229.80M | 150.40M | 108.41M | 89.11M | 67.64M | 31.84M | 11.17M | 10.74M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 551.56M | 510.28M | 300.90M | 194.57M | 149.47M | 121.30M | 95.67M | 48.63M | 19.45M | 12.65M |
Operating income | -515.29M | -458.16M | -267.85M | -136.58M | -106.36M | -90.87M | -69.55M | -32.15M | -13.40M | -5.22M |
Other income (expenses), net | 34.09M | -16.02M | -42K | 2.35M | 6.83M | 5.52M | 2.01M | 525K | 0 | -9.08M |
Income before tax | -481.19M | -474.18M | -267.89M | -134.23M | -99.53M | -85.34M | -67.54M | -31.63M | -13.40M | -14.30M |
Income tax expense | 0 | 16.02M | -8.17M | -8.66M | -6.83M | 5.52M | -2.99M | -1.10M | -1.01M | 0 |
Net income | -481.19M | -490.20M | -259.71M | -125.56M | -92.69M | -85.34M | -67.54M | -31.63M | -12.39M | -14.30M |
Earnings per share | ||||||||||
Basic EPS | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 | -1.88 | -1.42 | -0.7 | -29.45 |
Diluted EPS | -5.42 | -6.37 | -3.66 | -2.24 | -1.96 | -1.98 | -1.88 | -1.42 | -0.7 | -29.45 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |